nach oben

Current Psychiatry Reports

Erschienen in:

01.05.2014 | Child and Adolescent Disorders (T Benton, Section Editor)

Anorexia Nervosa and Bulimia Nervosa: Brains, Bones and Breeding

verfasst von: Taylor B. Starr, Richard E. Kreipe

Erschienen in: Current Psychiatry Reports | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Recent research has modified both the conceptualization and treatment of eating disorders. New diagnostic criteria reducing the “not otherwise specified” category should facilitate the early recognition and treatment of anorexia nervosa (AN) and bulimia nervosa (BN). Technology-based studies identify AN and BN as “brain circuit” disorders; epidemiologic studies reveal that the narrow racial, ethnic and income profile of individuals no longer holds true for AN. The major organs affected long term—the brain and skeletal system—both respond to improved nutrition, with maintenance of body weight the best predictor of recovery. Twin studies have revealed gene x environment interactions, including both the external (social) and internal (pubertal) environments of boys and of girls. Family-based treatment has the best evidence base for effectiveness for younger patients. Medication plays a limited role in AN, but a major role in BN. Across diagnoses, the most important medicine is food.

Gull WW. Anorexia Nervosa (Apepsia Hysterica, Anorexia Hysterica). R Clin Soc Lond Trans. 1873;vii:22.

2.••

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5: DSM-5th ed. Arlington: American Psychiatric Publishing; 2013. Less restrictive criteria, supported by clinical evidence, should facilitate earlier recognition.

Ornstein RM, Rosen DS, Mammel KA, et al. Distribution of eating disorders in children and adolescents using the proposed DSM-5 criteria for feeding and eating disorders. J Adolesc Health. 2013;53:303–5.PubMedCrossRef

Rosen DS, American Academy of Pediatrics Committee on Adolescence. Identification and management of eating disorders in children and adolescents. Pediatrics. 2010;126:1240–53.PubMedCrossRef

5.•

Wooldridge T, Lytle P. An overview of anorexia nervosa in males. Eat Disord J Treat Prev. 2012;20:68–78. Males are increasingly identified as underdiagnosed.CrossRef

Xanthopoulos MS, Borradaile KE, Hayes S, et al. The impact of weight, sex, and race/ethnicity on body dissatisfaction among urban children. Body Image. 2011;8:385–9.PubMedCrossRef

7.•

Gordon KH, Sitnikov L, Castro Y, et al. Cultural body shape ideals and eating disorder symptoms among White, Latina, and Black college women. Cult Divers Ethn Minor Psychol. 2010;16:135–43. Cultural and ethnic norms affect eating disorders.CrossRef

Marques L, Alegria M, Becker AE, et al. Comparative prevalence, correlates of impairment, and service utilization for eating disorders across US ethnic groups: implications for reducing ethnic disparities in health care access for eating disorders. Int J Eat Disord. 2011;44:412–20.PubMedCentralPubMedCrossRef

Rogers-Wood NA, Petrie TA. Body dissatisfaction, ethnic identity, and disordered eating among African American women. J Couns Psychol. 2010;57:141–53.PubMedCrossRef

10.

Becker AE, Arrindell AH, Perloe A, et al. A qualitative study of perceived social barriers to care for eating disorders: perspectives from ethnically diverse health care consumers. Int J Eat Disord. 2010;43:633–47.PubMedCentralPubMedCrossRef

11.••

Becker AE, Fay K, Agnew-Blais J, et al. Social network media exposure and adolescent eating pathology in Fiji. Br J Psychiatr. 2011;198:43–50. Landmark anthropological study of eating disorders developing in remote Pacific islands.CrossRef

12.

Peebles R, Wilson JL, Litt IF, et al. Disordered eating in a digital age: eating behaviors, health, and quality of life in users of websites with pro-eating disorder content. J Med Internet Res. 2012;14(5):e148.PubMedCentralPubMedCrossRef

13.

Datlof S, Coleman W, Forbes GB, et al. Ventricular dilation on CAT scans of patients with anorexia nervosa. Am J Psychiatr. 1986;143:96–8.PubMed

14.••

Lask B, Frampton I, editors. Eating disorders and the brain. Oxford: Wiley-Blackwell; 2011. Comprehensive, integrated book defining eating disorders as brain disorders.

15.•

Frank GKW, Kaye WH. Current status of functional imaging in eating disorders. Int J Eat Disord. 2012;45:723–36. Leading neuroscientists review brain-imaging studies.PubMedCrossRef

16.

Miller KM, Lee EE, Lawson EA, et al. Determinants of skeletal loss and recovery in A.N. J Clin Endocrinol Metab. 2006;91(8):2931–7.PubMedCentralPubMedCrossRef

17.•

Misra M, Klibanski A. Bone health in anorexia nervosa. Curr Opin Endocrinol Diabetes Obes. 2011;18(6):376–82. Review by leading researchers studying bone health.PubMedCentralPubMedCrossRef

18.

Grinspoon S, Thomas L, Miller K, et al. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab. 2002;87(6):2883–91.PubMedCrossRef

19.••

Misra M, Katzman D, Miller KK, et al. Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa. J Bone Miner Res. 2011;26(10):2430–8. Multicenter controlled clinical trial to increase BMD with treatment mirroring puberty.PubMedCentralPubMedCrossRef

20.

Javed A, Tebben PJ, Fischer PR, Lteif AN. Female athlete triad and its components: toward improved screening and management. Mayo Clin Proc. 2013;88(9):996–1009.PubMedCrossRef

21.

Klump KL, Miller KB, Keel PK, et al. Genetic and environmental influences on anorexia nervosa syndromes in a population-based twin sample. Psychol Med. 2001;31:737–40.PubMedCrossRef

22.

Bulik CM, Sullivan PF, Wade TD, et al. Twin studies of eating disorders: a review. Int J Eat Disord. 2000;27:1–20.PubMedCrossRef

23.

Slane JD, Burt SA, Klump KL. Genetic and environmental influences on disordered eating and depressive symptoms. Int J Eat Disord. 2011;44(7):605–11.PubMedCrossRef

24.

Favro A. Brain development and neurocircuit modeling are the interface between genetic/environmental risk factors and eating disorders. Int J Eat Disord. 2013;46:443–6.CrossRef

25.••

Klump KL, Culbert KM, Slane JD, et al. The effects of puberty on genetic risk for disordered eating: evidence for a sex difference. Psychol Med. 2012;42(3):627–37. Leading researchers in twin studies continue elegant work in gene x environment and epigenetic effects.PubMedCentralPubMedCrossRef

26.

Klump KL, Keel PK, Sisk C, et al. Preliminary evidence that estradiol moderates genetic influences on disordered eating attitudes and behaviors during puberty. Psychol Med. 2010;40(10):1745–53.PubMedCentralPubMedCrossRef

27.

Klump KL, Burt AS, Spanos A, et al. Age differences in genetic and environmental influences on weight and shape concerns. Int J Eat Disord. 2010;43:679–88.

28.••

Trace SE, Baker JH, Pefias-Lledó E, et al. The genetics of eating disorders. Ann Rev Clin Psychol. 2013;9:589–620. Comprehensive review of genetics in eating disorders.CrossRef

29.

Katzman DK, Peebles R, Sawyer SM, et al. The role of the pediatrician in family-based treatment for adolescent eating disorders: Opportunities and challenges. J Adolesc Health. 2013;53:433–40.PubMedCrossRef

30.

Lock J, leGrange D. Help your teenager beat an eating disorder. New York: Guilford Press; 2005.

31••.

leGrange D, Lock J. Eating disorders in children and adolescents: a clinical handbook. New York: Guilford Press; 2011. Comprehensive evidence-based clinical guide edited by leading researchers in family-based treatment.

32.

Couturier J, Kimber M, Szatmari P. Efficacy of family-based treatment for adolescents with eating disorders: a systematic review and meta-analysis. Int J Eat Disord. 2013;46:3–11.PubMedCrossRef

33.

Tantillo MD, Kreipe RE. Improving connections for adolescents across high-intensity settings for the treatment of eating disorders, Chapter in, eating disorders in children and adolescents: a clinical handbook. New York: Guilford Press; 2011. p. 199–222.

34.•

Milano W, De Rosa M, Milano L, et al. The pharmacological options in the treatment of eating disorders. ISRN Pharmacol. 2013;Jul 15: 352865. eCollection. Comprehensive review of all medications with potential therapeutic effects in eating disorders.

35.

Hay PJ, Claudino AM. Clinical psychopharmacology of eating disorder: a research update. Int J Neuropsychopharmacol. 2011;6:1–14.

36.

Lebow J, Sim LA, Erwin PJ, Murad MH. The effect of atypical antipsychotic medications in individuals with anorexia nervosa: A systematic review and meta-analysis. Internat J Eat Disord 2013;46:332-39.

37.

Powers PS, Santana C. Available pharmacological treatments for anorexia nervosa. Expert Opin Pharmacother. 2004;5:2287–92.PubMedCrossRef

38.

Hedges DW, Reimherr FW, Hoopes SP, et al. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial—part 2: improvement in psychiatric measures. J Clin Psychiatry. 2003;64:1449–54.PubMedCrossRef

39.

Hoopes SP, Reimherr FW, Hedges DW, et al. Treatment of bulimia nervosa with topriamate in a randomized, double-blind, placebo controlled trial—part 1: improvement in psychiatric measures. J Clin Psychiatry. 2003;64:1335–41.PubMedCrossRef

40.

Ricca V, Castellini G, LoSauro C, et al. Zonisamide combined with cognitive behavioral therapy in binge eating disorder: a one-year follow-up study. Psychiatry. 2009;6:23–8.PubMedCentralPubMed

41.

Halmi KA, Eckert E, LaDu TJ, et al. Anorexia nervosa: treatment efficacy of cyproheptadine and Amitriptyline. Arch Gen Psychiatry. 1986;43:177–81.PubMedCrossRef

42.

Hotta M, Ohwada R, Akamizu T, et al. Therapeutic potential of ghrelin in restricting-type anorexia nervosa. Methods Enzymol. 2012;514:381–98.

Titel: Anorexia Nervosa and Bulimia Nervosa: Brains, Bones and Breeding
verfasst von: Taylor B. Starr
Richard E. Kreipe
Publikationsdatum: 01.05.2014
Verlag: Springer US
Erschienen in: Current Psychiatry Reports / Ausgabe 5/2014
Print ISSN: 1523-3812
Elektronische ISSN: 1535-1645
DOI: https://doi.org/10.1007/s11920-014-0441-4

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2014

Physical and Social Pains in Borderline Disorder and Neuroanatomical Correlates: A Systematic Review

Pediatric Feeding and Eating Disorders: Current State of Diagnosis and Treatment